Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-κB and STAT3 inhibitors
Binglin Zeng, Yu Cheng, Kailu Zheng, Shuoxiao Liu, Longying Shen, Jinping Hu, Yan Li, Xiandao Pan
Topics & Concepts
ParthenolideTemozolomideIn vivoChemistryPharmacologyCytotoxicityApoptosisImmune systemNF-κBIn vitroCancer researchGliomaBiochemistryImmunologyMedicineBiologyBiotechnologyNF-κB Signaling PathwaysSesquiterpenes and Asteraceae StudiesCytokine Signaling Pathways and Interactions